Pegasus Partners’s Cigna CI Stock Holding History

Pegasus Partners’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-18,174	Closed	-$3.04M	–	155
2017 Q2	$3.04M	Buy	+18,174	New	+$2.92M	0.81%	41

Other funds holding CI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Pegasus Partners's CI Position: Q3 2017 in Review

Pegasus Partners sold out of Cigna (CI) in Q3 2017, closing a stake of 18,174 shares — an estimated $3.04M sold.

Pegasus Partners first reported a position in CI in Q2 2017 and held it in 1 quarter. The position peaked at $3.04M in Q2 2017. 786 funds tracked by Wall St. Rank hold CI as of Q3 2017.

Pegasus Partners reported no remaining Cigna position as of Q3 2017 after selling out during the quarter.
Pegasus Partners sold 18,174 Cigna shares in Q3 2017, an estimated $3.04M.
Pegasus Partners first reported a position in Cigna in Q2 2017 and held it in 1 quarter.
Pegasus Partners's Cigna position peaked at $3.04M in Q2 2017.
786 funds tracked by Wall St. Rank held Cigna as of Q3 2017.

Based on Pegasus Partners's 13F filing for Q3 2017, filed 9 Nov 2017.